Hemp Cultivation, Processing & Extraction News

Surprise surprise.. not NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Canopy Growth Corporation and certain of its officers and/or directors have engaged in securities fraud or other unlawful business

Mass Live A Western Massachusetts marijuana cultivator sued a neighboring farm Tuesday for more than $17 million, accusing it of negligently spraying pesticides that contaminated a year of weed crops and brought future growth to a standstill. The Hatfield farm, River Valley Growers, said its entire 2022 marijuana crop, weighing some 47,000 pounds, was tainted by pesticides that drifted

In what may have been the state’s first felony prosecution involving Delta-8-THC products, our firm was able to get our client’s felony drug charges completely dismissed this week, and we helped him recover almost $20,000 that law enforcement seized from his business, a regional vape store chain in the metro Atlanta area. Back in 2021,

A new class action lawsuit has been filed against Smoore, the parent company of cannabis vape brand CCELL, and its U.S.-based distributors, accusing them of illegally fixing prices and using patent litigation to maintain a monopoly over the cannabis vape hardware market. The lawsuit, filed by Arizona-based Earth’s Healing, Inc., alleges violations of the Sherman Act

MJ Biz reports Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex. The Ireland-based company, according to Green Market Report, filed its 2023 patent-enforcement lawsuit against a dozen alleged infringers, including: Alkem Laboratories API Pharma Tech Apotex Ascent Pharmaceuticals Biophore Pharma InvaGen Pharmaceuticals and its parent, Cipla USA Lupin MSN Pharmaceuticals Padagis

I’m glad somebody else has done it Here’s their introduction From legal complaints to a recent public health advisory, it all comes down to laboratory testing standards and enforcement Legal threats and litigation aren’t new phenomena in Massachusetts cannabis. Since before the first licensees planted seeds, lawyers have lined their pockets off of more than

Thanks to Vince Sliwoski for tipping us off to this only in Oregon story ! A man who was getting baked while bare of any clothes was seriously injured when his weed pen exploded, a lawsuit filed Friday claims. Gustavo Mendes now seeks $230,000 from the manufacturer of the malfunctioning marijuana vaporizer and the Eugene

Marijuana Moment digs into the ruling by the federal appeals court who sent the case back to the district court to consider again A federal appeals court panel has dismissed a three-year prison sentence against a person convicted for possession of a firearm while being an active user of marijuana, ruling that the federal government’s

MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the Medical Marijuana Research Expansion Act. MMJ accuses the DEA of bias in restricting MMJ to cultivate its proprietary marijuana cultivars necessary for research and pharmaceutical drug manufacturing.

Abstract South Africa’s interaction with Cannabis sativa L.—locally known as dagga or ntsangu—spans centuries and reflects the nation’s complex history. Early prohibition, influenced by colonial dynamics, set the stage for the apartheid regime’s stringent criminalisation of dagga users and growers during the ensuing decades, further enshrined in a 1992 law (two years before the fall of the